Projekte unter der Sponsorschaft der AIO-Studien-gGmbH

Lebensqualität und PRO

AIO-LQ-0110: Comparison of two preemptive treatment strategies of panitumumab mediated skin toxicity and assessment of quality of life in patients with kras-wildtype colorectal cancer